Brain-penetrant calcium channel blockers are associated with a reduced incidence of neuropsychiatric disorders

HIGHLIGHTS

• who: Lucy Colbourne from the (UNIVERSITY) have published the research work: Brain-penetrant calcium channel blockers are associated with a reduced incidence of neuropsychiatric disorders, in the Journal: (JOURNAL) of 26/05/2022
• what: For this study, the authors dichotomised the dihydropyridine CCBs into those generally considered to have high brain penetrability and those which do not. Using electronic health records the authors show that over a two-year period, compared to amlodipine, BP-CCBs are associated with lower risks for receiving a first diagnosis of a range of psychiatric disorders as well as for . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.